A detailed history of Nuveen Asset Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,061,157 shares of INSM stock, worth $77.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,061,157
Previous 1,329,947 20.21%
Holding current value
$77.9 Million
Previous $89.1 Million 13.07%
% of portfolio
0.02%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $16.7 Million - $21.2 Million
-268,790 Reduced 20.21%
1,061,157 $77.5 Million
Q2 2024

Aug 09, 2024

BUY
$22.0 - $69.71 $17.4 Million - $55.3 Million
792,716 Added 147.56%
1,329,947 $89.1 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $4.12 Million - $4.79 Million
160,016 Added 42.42%
537,231 $14.6 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $666,275 - $902,971
28,449 Added 8.16%
377,215 $11.7 Million
Q3 2023

Nov 14, 2023

SELL
$19.86 - $26.93 $140,529 - $190,556
-7,076 Reduced 1.99%
348,766 $8.81 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $31,745 - $40,744
1,931 Added 0.55%
355,842 $7.51 Million
Q1 2023

May 15, 2023

SELL
$16.26 - $21.73 $11.4 Million - $15.3 Million
-702,679 Reduced 66.5%
353,911 $6.03 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $3.95 Million - $5.38 Million
232,374 Added 28.19%
1,056,590 $21.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $7.16 Million - $9.67 Million
342,694 Added 71.17%
824,216 $17.8 Million
Q2 2022

Aug 15, 2022

SELL
$17.07 - $25.71 $401,981 - $605,444
-23,549 Reduced 4.66%
481,522 $9.5 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $12,803 - $17,637
627 Added 0.12%
505,071 $11.7 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $793,010 - $1.02 Million
-30,630 Reduced 5.72%
504,444 $13.3 Million
Q3 2021

Nov 12, 2021

SELL
$22.46 - $29.47 $657,718 - $862,999
-29,284 Reduced 5.19%
535,074 $14.3 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $62,141 - $92,581
2,571 Added 0.46%
564,358 $16.1 Million
Q1 2021

May 17, 2021

SELL
$32.28 - $44.3 $1.3 Million - $1.78 Million
-40,206 Reduced 6.68%
561,787 $19.1 Million
Q4 2020

May 17, 2021

SELL
$31.45 - $40.54 $970,326 - $1.25 Million
-30,853 Reduced 4.88%
601,993 $20 Million
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $2.94 Million - $3.79 Million
93,595 Added 17.36%
632,846 $21.1 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $938,002 - $1.24 Million
-36,077 Reduced 6.27%
539,251 $17.3 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $323,034 - $673,541
22,894 Added 4.14%
575,328 $15.8 Million
Q1 2020

May 14, 2020

SELL
$13.63 - $33.98 $431,771 - $1.08 Million
-31,678 Reduced 5.42%
552,434 $8.86 Million
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $1.84 Million - $2.85 Million
114,232 Added 24.31%
584,112 $13.9 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $1.08 Million - $1.8 Million
69,837 Added 17.46%
469,880 $8.29 Million
Q2 2019

Aug 15, 2019

BUY
$23.0 - $32.19 $9.2 Million - $12.9 Million
400,043 New
400,043 $10.2 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.94B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.